Growth Metrics

RemSleep Holdings (RMSL) Return on Invested Capital (2017 - 2018)

RemSleep Holdings recorded quarterly Return on Invested Capital of 0.02% in Q1 2018, down 16.67% quarter-over-quarter from 0.02% in Q4 2017.

RemSleep Holdings' Return on Invested Capital history runs 2 years deep, the most recent figure standing at 0.02% for Q1 2018.

  • In Q1 2018, Return on Invested Capital changed N/A year-over-year to 0.02%; the TTM figure through Mar 2018 stood at 0.02% (changed N/A YoY), while the FY2025 annual figure was 0.15%, down 14.0% from the prior year.
  • Return on Invested Capital came in at 0.02% for Q1 2018 at RemSleep Holdings, down from 0.02% in the prior quarter.
  • In the past five years, Return on Invested Capital ranged from a high of 0.02% in Q4 2017 to a low of 0.02% in Q1 2018.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROIC (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn 0.00%
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 0.00%
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 0.00%
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 0.00%
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn 0.00%
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 0.00%
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 0.00%
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 0.00%
10 RemSleep Holdings - - -7,636.00 -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2018 0.02%
Dec 31, 2017 0.02%